ADC Therapeutics is up 9.7%, or 31c to $3.49.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ADCT:
- ADCT Soars Following EU Approval For Cancer Drug
- ADC, Sobi announce EC grants conditional marketing authorization for Zynlonta
- ADC Therapeutics CFO Jenn Creel to depart, Jose Carmona to succeed
- Freenome presents research on its multiomics platform
- Biocytogen enters antibody agreement with ADC Therapeutics